World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
20775
World Ranking
4135
National Ranking
2028

Nouri Neamati publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Nouri Neamati sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 321 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Nouri Neamati D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Nouri Neamati sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 80 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Nouri Neamati is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily spans the fields of biochemistry, genetics, molecular biology, and medicine, with specific emphasis on molecular biology, oncology, cell biology, infectious diseases, and epidemiology.

The scientist's recent publications highlight a focus on molecular mechanisms related to disease processes, cancer, and cellular stress responses. Notable papers include:

  • Role of the ERO1-PDI interaction in oxidative protein folding and disease (2020, Pharmacology & Therapeutics)
  • Why All the Fuss about Oxidative Phosphorylation (OXPHOS)? (2020, Journal of Medicinal Chemistry)
  • The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer (2021, Cancer Research)
  • Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy (2023, Nature Communications)
  • Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91 (2021, Journal of Medicinal Chemistry)

The main topics of their work include:

  • Endoplasmic Reticulum Stress and Disease
  • Autophagy in Disease and Therapy
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer
  • SARS-CoV-2 and COVID-19 Research
  • Cytokine Signaling Pathways and Interactions
  • COVID-19 Clinical Research Studies

Neamati's frequent co-authors reflect collaborations across several prominent researchers, including Mats Ljungman, Armita Kyani, Yibin Xu, Ding Xue, and Duxin Sun.

The scientist has published extensively in respected academic venues, with a significant number of papers appearing in:

  • Journal of Medicinal Chemistry
  • European Journal of Medicinal Chemistry
  • ACS Pharmacology & Translational Science
  • Cancer Research
  • Neoplasia

Their work addresses complex biomedical challenges such as oxidative protein folding, apoptosis in cancer cells, and innovative chemoimmunotherapy approaches involving nanomedicine. This research portfolio encompasses experimental and mechanistic studies, often focusing on molecular targets relevant to cancer and infectious diseases.

Best Publications

  • Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases

    Helen Ha;Bikash Debnath;Nouri Neamati

  • Coumarin-based inhibitors of HIV integrase.

    He Zhao;Nouri Neamati;Huixiao Hong;Abhijit Mazumder

  • Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.

    Xiaoyuan Chen;Carmen Plasencia;Yingping Hou;Nouri Neamati

  • Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.

    Nouri Neamati;Huixiao Hong;Abhijit Mazumder;Shaomeng Wang

  • Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism

    Divya Pathania;Melissa Millard;Nouri Neamati

  • Small Molecule Inhibitors of CXCR4

    Bikash Debnath;Shili Xu;Fedora Grande;Antonio Garofalo

  • Protein disulfide isomerase: a promising target for cancer therapy.

    Shili Xu;Saranya Sankar;Nouri Neamati

  • Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.

    Godwin C. G. Pais;Xuechun Zhang;Christophe Marchand;Nouri Neamati

  • Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4

    Qian Zhao;Liying Ma;Shibo Jiang;Hong Lu

  • In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide.

    Yanbin Ji;Subhabrata Majumder;Melissa Millard;Radhika Borra

  • Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment

    Shili Xu;Alexey N. Butkevich;Roppei Yamada;Yu Zhou

  • Chicoric acid analogues as HIV-1 integrase inhibitors.

    Zhaiwei Lin;Nouri Neamati;He Zhao;Yoshimitsu Kiryu

  • Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein

    Bikash Debnath;Shili Xu;Nouri Neamati

  • HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.

    Marc C. Nicklaus;Nouri Neamati;Huixiao Hong;Abhijit Mazumder

  • Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

    Erik Serrao;Srinivas Odde;Kavya Ramkumar;Nouri Neamati

  • Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

    Abhijit Mazumder;Shaomeng Wang;Nouri Neamati;Marc Nicklaus

  • Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.

    Kentaro Nakayama;Atsuko Kanzaki;Kenji Ogawa;Kohji Miyazaki

  • Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.

    Jinxia Deng;Tino Sanchez;Laith Q. Al-Mawsawi;Raveendra Dayam

  • Structural Determinants for HIV-1 Integrase Inhibition by β-Diketo Acids

    Christophe Marchand;Xuechun Zhang;Godwin C.G. Pais;Kiriana Cowansage

  • Design and Synthesis of Novel Indole β-Diketo Acid Derivatives as HIV-1 Integrase Inhibitors

    Mario Sechi;Massimiliano Derudas;Roberto Dallocchio;Alessandro Dessì

Frequent Co-Authors

Zeger Debyser
Zeger Debyser KU Leuven
Frauke Christ
Frauke Christ KU Leuven
Terrence R. Burke
Terrence R. Burke National Institutes of Health
Fabrizio Carta
Fabrizio Carta University of Florence
Christoph H. Borchers
Christoph H. Borchers McGill University
Xiaoyuan Chen
Xiaoyuan Chen National University of Singapore
Nicos A. Petasis
Nicos A. Petasis University of Southern California
Valter D. Longo
Valter D. Longo University of Southern California
Gang Niu
Gang Niu Xi'an Jiaotong University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Biology or Biochemistry opens doors to diverse healthcare career options, both in direct science fields and in administrative roles. For students interested in the technical side of healthcare, medical coding is a popular and fast-growing path. To become a certified coder, it's important to understand the distinctions between different credentials, such as certified professional coder programs and other certifications.

The journey on medical coding salary potential shows that certified professionals can earn competitive wages, with added benefits like remote work flexibility. Still, it's wise to weigh both the rewards and challenges of this profession; discover more about the pros and cons of working in this field at is medical coding a good job.

Many aspiring professionals choose an online route to qualify for these positions. From certificates to full degrees, there are health information management online degree programs that are affordable and flexible for students. With the right online education, graduates can transition smoothly into high-demand healthcare roles.

Best Scientists Citing Nouri Neamati

Trending Scientists

Recently Published Articles